Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance

M. Sanni Ali; Klara Berencsi; Karine Marnier; Nicolas Deltour; Lars Pedersen; Peter Rijnbeek; Francesco Lapi; Monica Simonetti; Miriam Sturkenboom; Johan Van der Lei; Johan Van der Lei; Daniel Prieto-Alhambra

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance

M. Sanni Ali, Klara Berencsi, Karine Marnier, Nicolas Deltour, Lars Pedersen, Peter Rijnbeek, Francesco Lapi, Monica Simonetti, Miriam Sturkenboom, Johan Van der Lei, Johan Van der Lei, Daniel Prieto-Alhambra

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	186-187
Journal	Pharmacoepidemiology and Drug Safety
Volume	27
Publication status	Published - Aug 2018

Cite this

Ali, M. S., Berencsi, K., Marnier, K., Deltour, N., Pedersen, L., Rijnbeek, P., Lapi, F., Simonetti, M., Sturkenboom, M., Van der Lei, J., Van der Lei, J., & Prieto-Alhambra, D. (2018). Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance. Pharmacoepidemiology and Drug Safety, 27, 186-187.

@article{df89b738ff8945848a4a8b4913c78bc0,

title = "Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance",

author = "Ali, {M. Sanni} and Klara Berencsi and Karine Marnier and Nicolas Deltour and Lars Pedersen and Peter Rijnbeek and Francesco Lapi and Monica Simonetti and Miriam Sturkenboom and {Van der Lei}, Johan and {Van der Lei}, Johan and Daniel Prieto-Alhambra",

year = "2018",

month = aug,

language = "English",

volume = "27",

pages = "186--187",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley & Sons Inc.",

}

Ali, MS, Berencsi, K, Marnier, K, Deltour, N, Pedersen, L, Rijnbeek, P, Lapi, F, Simonetti, M, Sturkenboom, M, Van der Lei, J, Van der Lei, J & Prieto-Alhambra, D 2018, 'Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance', Pharmacoepidemiology and Drug Safety, vol. 27, pp. 186-187.

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance. / Ali, M. Sanni; Berencsi, Klara; Marnier, Karine et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 27, 08.2018, p. 186-187.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance

AU - Ali, M. Sanni

AU - Berencsi, Klara

AU - Marnier, Karine

AU - Deltour, Nicolas

AU - Pedersen, Lars

AU - Rijnbeek, Peter

AU - Lapi, Francesco

AU - Simonetti, Monica

AU - Sturkenboom, Miriam

AU - Van der Lei, Johan

AU - Prieto-Alhambra, Daniel

PY - 2018/8

Y1 - 2018/8

M3 - Meeting Abstract

SN - 1053-8569

VL - 27

SP - 186

EP - 187

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -